Harbin Pharmaceutical shares into health Anxi largest shareholder | product line upgrade

February 14 hearing, February 14, Harbin Pharmaceutical Group Co., Ltd. issued a statement that the US $ 5.35 per share, a total of 299,950,000 US dollars acquired 299,950 shares of the United States GNC shares, accounting for 40.1% of the total shares of GNC.

Founded in 1935 and headquartered in Pittsburgh, PA, GNC is the world's largest specialty retailer of health nutrition products and one of the nation's best-known health-care brands focused on the development and manufacturing of health products, The product line includes more than 1,500 health products such as vitamins and minerals products, sport and health nutrition products, herbal extract nutrition products and various kinds of dietary nutrition products, which are sold worldwide with an annual sales volume of over 600 million bottles.

Harbin Pharmaceutical shares are large-scale integrated pharmaceutical enterprise , Business coverage Healthy food , Chemical raw materials and preparations, traditional and modern Chinese medicine, biomedicine and so on, more than 400 kinds of main products, including vitamin mineral supplements products 'triple fine zinc gluconate oral solution' Star products.

Some analysts believe that Harbin Pharmaceutical shares of the inadequacies of the aging product line, the cooperation can greatly enrich its product line.Healthcare market has exceeded 100 billion yuan, with great potential and rapid growth, but the domestic lack of coverage Full product line of brand enterprises. And GNC (Health Ann) is the United States the largest health nutrition production and retail enterprises, the world-renowned products, domestic Health products The market is in dire need of such brand and product infusions to meet the rising health needs of consumers.

In recent years, Harbin Pharmaceutical shares actively build product traceability system, straighten out the sales channels in the country, closely linked terminals. Through the alliance with nearly 500 commercial customers, the sales network throughout the country more than 2500 counties and effectively maintain the sales terminal Over 400,000.

CFDA South medicine Lin Jianning, director of the Institute of Economic said Harbin Pharmaceutical Group has many years of brand precipitation product quality Excellent, brand enjoys popular support.In recent years, Harbin Pharmaceutical Group in the channel construction and product traceability system, made a lot of optimization management.I believe that Harbin Pharmaceutical Group as a pharmaceutical strong and GNC (Jian Anxi) cooperation to achieve complementary advantages , To create a new situation in China's health care products market has brought a breeze.